TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9321099
log Bayes Factor = 0.0811239
Chromosome 6   position 128,202,139  (GRCh37) Explore rs9321099 on Ensembl!
Variant rs9321099 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
I30-I52 Other forms of heart disease
0.000 0.880 0.120
I45 Other conduction disorders
0.000 0.881 0.119
I45.1 Other and unspecified right bundle-branch block
0.000 0.881 0.119
I49 Other cardiac arrhythmias
0.000 0.883 0.117
I42 Cardiomyopathy
0.000 0.886 0.114
I49.8 Other specified cardiac arrhythmias
0.000 0.888 0.112
I34 Nonrheumatic mitral valve disorders
0.000 0.890 0.110
I35 Nonrheumatic aortic valve disorders
0.000 0.891 0.109
I42.2 Other hypertrophic cardiomyopathy
0.000 0.893 0.107
I45.5 Other specified heart block
0.000 0.893 0.107
I42.1 Obstructive hypertrophic cardiomyopathy
0.000 0.894 0.106
I45.3 Trifascicular block
0.000 0.894 0.106
I51 Complications and ill-defined descriptions of heart disease
0.000 0.898 0.102
I51.9 Heart disease, unspecified
0.000 0.899 0.101
I49.4 Other and unspecified premature depolarisation
0.000 0.899 0.101
I34.1 Mitral (valve) prolapse
0.000 0.900 0.100
I35.8 Other aortic valve disorders
0.000 0.901 0.099
I35.1 Aortic (valve) insufficiency
0.000 0.903 0.097
I49.5 Sick sinus syndrome
0.000 0.903 0.097
I49.3 Ventricular premature depolarisation
0.000 0.907 0.093
I35.2 Aortic (valve) stenosis with insufficiency
0.000 0.907 0.093
I46 Cardiac arrest
0.000 0.907 0.093
I45.8 Other specified conduction disorders
0.000 0.910 0.090
I38 Endocarditis, valve unspecified
0.000 0.911 0.089
I33 Acute and subacute endocarditis
0.000 0.911 0.089
I30 Acute pericarditis
0.000 0.914 0.086
I52 Other heart disorders in diseases classified elsewhere
0.000 0.914 0.086
I48 Atrial fibrillation and flutter
0.000 0.914 0.086
I43 Cardiomyopathy in diseases classified elsewhere
0.000 0.914 0.086
I41 Myocarditis in diseases classified elsewhere
0.000 0.914 0.086
I40 Acute myocarditis
0.000 0.914 0.086
I39 Endocarditis and heart valve disorders in diseases classified elsewhere
0.000 0.914 0.086
I32 Pericarditis in diseases classified elsewhere
0.000 0.914 0.086
I45.0 Right fascicular block
0.000 0.914 0.085
I34.2 Nonrheumatic mitral (valve) stenosis
0.000 0.915 0.085
I50 Heart failure
0.000 0.916 0.084
I49.2 Junctional premature depolarisation
0.000 0.916 0.084
I49.1 Atrial premature depolarisation
0.000 0.918 0.082
I42.7 Cardiomyopathy due to drugs and other external agents
0.000 0.918 0.082
I42.5 Other restrictive cardiomyopathy
0.000 0.918 0.082
I42.4 Endocardial fibroelastosis
0.000 0.918 0.082
I42.3 Endomyocardial (eosinophilic) disease
0.000 0.918 0.082
I31 Other diseases of pericardium
0.000 0.919 0.081
I45.4 Nonspecific intraventricular block
0.000 0.920 0.080
I34.9 Nonrheumatic mitral valve disorder, unspecified
0.000 0.920 0.080
I51.3 Intracardiac thrombosis, not elsewhere classified
0.000 0.921 0.079
I42.9 Cardiomyopathy, unspecified
0.000 0.921 0.079
I34.8 Other nonrheumatic mitral valve disorders
0.000 0.921 0.079
I34.0 Mitral (valve) insufficiency
0.000 0.921 0.079
I36 Nonrheumatic tricuspid valve disorders
0.000 0.922 0.078
I42.6 Alcoholic cardiomyopathy
0.000 0.924 0.076
I46.9 Cardiac arrest, unspecified
0.000 0.924 0.076
I37 Pulmonary valve disorders
0.000 0.926 0.074
I51.5 Myocardial degeneration
0.000 0.927 0.073
I51.2 Rupture of papillary muscle, not elsewhere classified
0.000 0.927 0.073
I42.8 Other cardiomyopathies
0.000 0.927 0.072
I45.2 Bifascicular block
0.000 0.928 0.072
I49.9 Cardiac arrhythmia, unspecified
0.000 0.928 0.072
I35.9 Aortic valve disorder, unspecified
0.000 0.931 0.068
I51.6 Cardiovascular disease, unspecified
0.000 0.932 0.068
I50.9 Heart failure, unspecified
0.000 0.932 0.068
I51.7 Cardiomegaly
0.000 0.932 0.068
I46.1 Sudden cardiac death, so described
0.000 0.933 0.067
I33.0 Acute and subacute infective endocarditis
0.000 0.933 0.067
I45.9 Conduction disorder, unspecified
0.000 0.934 0.066
I51.0 Cardiac septal defect, acquired
0.000 0.935 0.065
I33.9 Acute endocarditis, unspecified
0.000 0.936 0.064
I30.1 Infective pericarditis
0.000 0.936 0.063
I44 Atrioventricular and left bundle-branch block
0.000 0.937 0.063
I51.1 Rupture of chordae tendineae, not elsewhere classified
0.000 0.937 0.063
I46.0 Cardiac arrest with successful resuscitation
0.000 0.937 0.063
C18 Malignant neoplasm of colon
0.062 0.938 0.000
I30.8 Other forms of acute pericarditis
0.000 0.938 0.062
I30.0 Acute nonspecific idiopathic pericarditis
0.000 0.938 0.062
I32.8 Pericarditis in other diseases classified elsewhere
0.000 0.938 0.062
I32.1 Pericarditis in other infectious and parasitic diseases classified elsewhere
0.000 0.938 0.062
I32.0 Pericarditis in bacterial diseases classified elsewhere
0.000 0.938 0.062
I39.8 Endocarditis, valve unspecified, in diseases classified elsewhere
0.000 0.938 0.062
I39.4 Multiple valve disorders in diseases classified elsewhere
0.000 0.938 0.062
I39.3 Pulmonary valve disorders in diseases classified elsewhere
0.000 0.938 0.062
I39.2 Tricuspid valve disorders in diseases classified elsewhere
0.000 0.938 0.062
I39.1 Aortic valve disorders in diseases classified elsewhere
0.000 0.938 0.062
I39.0 Mitral valve disorders in diseases classified elsewhere
0.000 0.938 0.062
I40.9 Acute myocarditis, unspecified
0.000 0.938 0.062
I40.8 Other acute myocarditis
0.000 0.938 0.062
I40.1 Isolated myocarditis
0.000 0.938 0.062
I40.0 Infective myocarditis
0.000 0.938 0.062
I41.8 Myocarditis in other diseases classified elsewhere
0.000 0.938 0.062
I41.2 Myocarditis in other infectious and parasitic diseases classified elsewhere
0.000 0.938 0.062
I41.1 Myocarditis in viral diseases classified elsewhere
0.000 0.938 0.062
I41.0 Myocarditis in bacterial diseases classified elsewhere
0.000 0.938 0.062
I43.8 Cardiomyopathy in other diseases classified elsewhere
0.000 0.938 0.062
I43.2 Cardiomyopathy in nutritional diseases
0.000 0.938 0.062
I43.1 Cardiomyopathy in metabolic diseases
0.000 0.938 0.062
I43.0 Cardiomyopathy in infectious and parasitic diseases classified elsewhere
0.000 0.938 0.062
I48.9 Atrial fibrillation and atrial flutter, unspecified
0.000 0.938 0.062
I48.4 Atypical atrial flutter
0.000 0.938 0.062
I48.3 Typical atrial flutter
0.000 0.938 0.062
I48.2 Chronic atrial fibrillation
0.000 0.938 0.062
I48.1 Persistent atrial fibrillation
0.000 0.938 0.062
I48.0 Paroxysmal atrial fibrillation
0.000 0.938 0.062
I52.8 Other heart disorders in other diseases classified elsewhere
0.000 0.938 0.062
I52.1 Other heart disorders in other infectious and parasitic diseases classified elsewhere
0.000 0.938 0.062
I52.0 Other heart disorders in bacterial diseases classified elsewhere
0.000 0.938 0.062
C18.3 Hepatic flexure
0.062 0.938 0.000
I31.3 Pericardial effusion (noninflammatory)
0.000 0.938 0.062
C15-C26 Malignant neoplasms of digestive organs
0.061 0.939 0.000
I30.9 Acute pericarditis, unspecified
0.000 0.939 0.061
C19 Malignant neoplasm of rectosigmoid junction
0.059 0.941 0.000
I42.0 Dilated cardiomyopathy
0.000 0.941 0.058
I31.8 Other specified diseases of pericardium
0.000 0.942 0.058
I31.2 Haemopericardium, not elsewhere classified
0.000 0.942 0.058
I31.1 Chronic constrictive pericarditis
0.000 0.942 0.058
I31.0 Chronic adhesive pericarditis
0.000 0.942 0.058
I36.9 Nonrheumatic tricuspid valve disorder, unspecified
0.000 0.944 0.056
I36.8 Other nonrheumatic tricuspid valve disorders
0.000 0.944 0.056
I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency
0.000 0.944 0.056
I36.0 Nonrheumatic tricuspid (valve) stenosis
0.000 0.944 0.056
I44.0 Atrioventricular block, first degree
0.000 0.944 0.056
I50.0 Congestive heart failure
0.000 0.944 0.056
C18.2 Ascending colon
0.055 0.945 0.000
I49.0 Ventricular fibrillation and flutter
0.000 0.945 0.055
I51.8 Other ill-defined heart diseases
0.000 0.945 0.055
I51.4 Myocarditis, unspecified
0.000 0.946 0.054
I50.1 Left ventricular failure
0.000 0.946 0.054
I37.9 Pulmonary valve disorder, unspecified
0.000 0.946 0.053
I37.8 Other pulmonary valve disorders
0.000 0.946 0.053
I37.2 Pulmonary valve stenosis with insufficiency
0.000 0.946 0.053
I37.0 Pulmonary valve stenosis
0.000 0.946 0.053
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.053 0.947 0.000
C20 Malignant neoplasm of rectum
0.053 0.947 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.052 0.948 0.000
C18.9 Colon, unspecified
0.050 0.950 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.050 0.950 0.000
C18.5 Splenic flexure
0.049 0.951 0.000
I31.9 Disease of pericardium, unspecified
0.000 0.951 0.049
C18.8 Overlapping lesion of colon
0.048 0.952 0.000
C18.6 Descending colon
0.048 0.952 0.000
I36.1 Nonrheumatic tricuspid (valve) insufficiency
0.000 0.952 0.047
C22.1 Intrahepatic bile duct carcinoma
0.047 0.952 0.000
C17 Malignant neoplasm of small intestine
0.047 0.953 0.000
C18.7 Sigmoid colon
0.046 0.954 0.000
I44.5 Left posterior fascicular block
0.000 0.955 0.045
I44.4 Left anterior fascicular block
0.000 0.955 0.045
I44.6 Other and unspecified fascicular block
0.000 0.955 0.045
C18.0 Caecum
0.044 0.956 0.000
C26.9 Ill-defined sites within the digestive system
0.043 0.957 0.000
I44.1 Atrioventricular block, second degree
0.000 0.957 0.043
C15 Malignant neoplasm of oesophagus
0.043 0.957 0.000
I37.1 Pulmonary valve insufficiency
0.000 0.958 0.041
C16 Malignant neoplasm of stomach
0.042 0.958 0.000
C24.0 Extrahepatic bile duct
0.041 0.959 0.000
C23 Malignant neoplasm of gallbladder
0.041 0.959 0.000
C26.0 Intestinal tract, part unspecified
0.041 0.959 0.000
C21 Malignant neoplasm of anus and anal canal
0.041 0.959 0.000
I44.2 Atrioventricular block, complete
0.000 0.960 0.040
C18.1 Appendix
0.038 0.962 0.000
C22.7 Other specified carcinomas of liver
0.038 0.962 0.000
C22.4 Other sarcomas of liver
0.038 0.962 0.000
C22.3 Angiosarcoma of liver
0.038 0.962 0.000
C22.2 Hepatoblastoma
0.038 0.962 0.000
C22.0 Liver cell carcinoma
0.038 0.962 0.000
C22.9 Liver, unspecified
0.038 0.962 0.000
C26.8 Overlapping lesion of digestive system
0.037 0.963 0.000
C26.1 Spleen
0.037 0.963 0.000
C17.0 Duodenum
0.037 0.963 0.000
C24.1 Ampulla of Vater
0.037 0.963 0.000
I44.3 Other and unspecified atrioventricular block
0.000 0.963 0.037
C24.9 Biliary tract, unspecified
0.036 0.964 0.000
C24.8 Overlapping lesion of biliary tract
0.036 0.964 0.000
C17.2 Ileum
0.035 0.965 0.000
C17.8 Overlapping lesion of small intestine
0.034 0.966 0.000
C17.3 Meckel's diverticulum
0.034 0.966 0.000
C17.1 Jejunum
0.034 0.966 0.000
C15.9 Oesophagus, unspecified
0.034 0.966 0.000
C17.9 Small intestine, unspecified
0.033 0.967 0.000
C16.9 Stomach, unspecified
0.032 0.968 0.000
C15.3 Upper third of oesophagus
0.031 0.969 0.000
C15.8 Overlapping lesion of oesophagus
0.031 0.969 0.000
C15.2 Abdominal part of oesophagus
0.031 0.969 0.000
C15.1 Thoracic part of oesophagus
0.031 0.969 0.000
C15.0 Cervical part of oesophagus
0.031 0.969 0.000
C21.8 Overlapping lesion of rectum, anus and anal canal
0.031 0.969 0.000
C18.4 Transverse colon
0.030 0.969 0.000
I45.6 Preexcitation syndrome
0.001 0.970 0.029
C16.8 Overlapping lesion of stomach
0.030 0.970 0.000
C16.6 Greater curvature of stomach, unspecified
0.030 0.970 0.000
C16.5 Lesser curvature of stomach, unspecified
0.030 0.970 0.000
C16.4 Pylorus
0.030 0.970 0.000
C16.1 Fundus of stomach
0.030 0.970 0.000
C16.2 Body of stomach
0.029 0.970 0.000
C21.2 Cloacogenic zone
0.029 0.971 0.000
C15.5 Lower third of oesophagus
0.029 0.971 0.000
C15.4 Middle third of oesophagus
0.029 0.971 0.000
C16.3 Pyloric antrum
0.028 0.972 0.000
C21.1 Anal canal
0.028 0.972 0.000
C25 Malignant neoplasm of pancreas
0.028 0.972 0.000
C16.0 Cardia
0.027 0.973 0.000
C21.0 Anus, unspecified
0.026 0.974 0.000
Y42.5 Other oestrogens and progestogens
0.024 0.976 0.000
I47 Paroxysmal tachycardia
0.000 0.978 0.022
N94.6 Dysmenorrhoea, unspecified
0.000 0.978 0.022
C25.1 Body of pancreas
0.020 0.980 0.000
C25.8 Overlapping lesion of pancreas
0.020 0.980 0.000
C25.7 Other parts of pancreas
0.020 0.980 0.000
C25.4 Endocrine pancreas
0.020 0.980 0.000
C25.3 Pancreatic duct
0.020 0.980 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.020 0.980 0.000
L57.0 Actinic keratosis
0.000 0.980 0.020
K51.8 Other ulcerative colitis
0.019 0.981 0.000
I35.0 Aortic (valve) stenosis
0.000 0.981 0.019
C25.2 Tail of pancreas
0.018 0.982 0.000
I44.7 Left bundle-branch block, unspecified
0.000 0.982 0.018
C25.0 Head of pancreas
0.018 0.982 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.017 0.983 0.000
Y42.1 Thyroid hormones and substitutes
0.016 0.983 0.000
Y42.7 Androgens and anabolic congeners
0.016 0.983 0.000
I47.9 Paroxysmal tachycardia, unspecified
0.000 0.985 0.015
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.015 0.985 0.000
Y42.9 Other and unspecified hormone antagonists
0.014 0.986 0.000
Y42.4 Oral contraceptives
0.014 0.986 0.000
Y42.2 Antithyroid drugs
0.014 0.986 0.000
K70.9 Alcoholic liver disease, unspecified
0.000 0.986 0.014
Y43 Primarily systemic agents
0.014 0.986 0.000
E11.3 With ophthalmic complications
0.000 0.987 0.013
K70 Alcoholic liver disease
0.000 0.987 0.013
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.013 0.987 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.987 0.013
I47.0 Reentry ventricular arrhythmia
0.000 0.987 0.013
Y43.0 Antiallergic and antiemetic drugs
0.013 0.987 0.000
K70.1 Alcoholic hepatitis
0.000 0.987 0.013
Y49 Psychotropic drugs, not elsewhere classified
0.013 0.987 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.012 0.987 0.000
C25.9 Pancreas, unspecified
0.012 0.988 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.012 0.988 0.000
K76.9 Liver disease, unspecified
0.000 0.988 0.012
K76 Other diseases of liver
0.000 0.988 0.012
E11.4 With neurological complications
0.000 0.988 0.012
K76.0 Fatty (change of) liver, not elsewhere classified
0.000 0.988 0.012
Y46 Antiepileptics and anti-Parkinsonism drugs
0.012 0.988 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.012 0.988 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.012 0.988 0.000
E11.2 With renal complications
0.000 0.988 0.011
K70.3 Alcoholic cirrhosis of liver
0.000 0.988 0.011
Y57 Other and unspecified drugs and medicaments
0.011 0.989 0.000
Y49.2 Other and unspecified antidepressants
0.011 0.989 0.000
E11.1 With ketoacidosis
0.000 0.989 0.011
Y53 Agents primarily affecting the gastro-intestinal system
0.011 0.989 0.000
E11.5 With peripheral circulatory complications
0.000 0.989 0.011
Y59 Other and unspecified vaccines and biological substances
0.011 0.989 0.000
Y58 Bacterial vaccines
0.011 0.989 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.011 0.989 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.011 0.989 0.000
Y48 Anaesthetics and therapeutic gases
0.011 0.989 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.011 0.989 0.000
Y43.3 Other antineoplastic drugs
0.011 0.989 0.000
Y41.0 Sulphonamides
0.011 0.989 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.011 0.989 0.000
Y44 Agents primarily affecting blood constituents
0.011 0.989 0.000
Y43.1 Antineoplastic antimetabolites
0.011 0.989 0.000
E11.6 With other specified complications
0.000 0.990 0.010
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.010 0.990 0.000
Y45.2 Propionic acid derivatives
0.010 0.990 0.000
Y43.9 Primarily systemic agent, unspecified
0.010 0.990 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.010 0.990 0.000
Y43.6 Enzymes, not elsewhere classified
0.010 0.990 0.000
Y43.5 Acidifying and alkalising agents
0.010 0.990 0.000
Y43.2 Antineoplastic natural products
0.010 0.990 0.000
K76.8 Other specified diseases of liver
0.000 0.990 0.010
K70.2 Alcoholic fibrosis and sclerosis of liver
0.000 0.990 0.010
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.000 0.990 0.010
E11.7 With multiple complications
0.000 0.990 0.010
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.010 0.990 0.000
Y57.9 Drug or medicament, unspecified
0.010 0.990 0.000
E11.8 With unspecified complications
0.000 0.990 0.010
K70-K77 Diseases of liver
0.000 0.990 0.010
E10-E14 Diabetes mellitus
0.000 0.991 0.009
Y46.4 Iminostilbenes
0.009 0.991 0.000
Y54.8 Agents affecting uric acid metabolism
0.009 0.991 0.000
Y46.2 Hydantoin derivatives
0.009 0.991 0.000
Y49.9 Psychotropic drug, unspecified
0.009 0.991 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.009 0.991 0.000
Y49.7 Psychostimulants with abuse potential
0.009 0.991 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.009 0.991 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.009 0.991 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.009 0.991 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.009 0.991 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.009 0.991 0.000
Y49.5 Other antipsychotics and neuroleptics
0.009 0.991 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.009 0.991 0.000
Y41.5 Antiviral drugs
0.009 0.991 0.000
Y41.4 Anthelminthics
0.009 0.991 0.000
Y41.3 Other antiprotozoal drugs
0.009 0.991 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.009 0.991 0.000
Y41.1 Antimycobacterial drugs
0.009 0.991 0.000
Y57.8 Other drugs and medicaments
0.009 0.991 0.000
Y54.4 Loop [high-ceiling] diuretics
0.009 0.991 0.000
N72 Inflammatory disease of cervix uteri
0.000 0.991 0.009
K70.4 Alcoholic hepatic failure
0.000 0.991 0.009
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.009 0.991 0.000
K76.5 Hepatic veno-occlusive disease
0.000 0.991 0.009
K76.4 Peliosis hepatis
0.000 0.991 0.009
K76.3 Infarction of liver
0.000 0.991 0.009
K76.2 Central haemorrhagic necrosis of liver
0.000 0.991 0.009
K76.1 Chronic passive congestion of liver
0.000 0.991 0.009
Y54.5 Other diuretics
0.009 0.991 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.991 0.009
E11.0 With coma
0.000 0.991 0.009
Y46.8 Antispasticity drugs
0.009 0.991 0.000
Y46.7 Anti-Parkinsonism drugs
0.009 0.991 0.000
Y46.5 Valproic acid
0.009 0.991 0.000
Y46.3 Deoxybarbiturates
0.009 0.991 0.000
Y46.1 Oxazolidinediones
0.009 0.991 0.000
Y46.0 Succinimides
0.009 0.991 0.000
K76.7 Hepatorenal syndrome
0.000 0.991 0.009
Y46.6 Other and unspecified antiepileptics
0.009 0.991 0.000
Y45.0 Opioids and related analgesics
0.009 0.991 0.000
K70.0 Alcoholic fatty liver
0.000 0.991 0.009
Y54.9 Mineral salts, not elsewhere classified
0.009 0.991 0.000
Y54.7 Agents affecting calcification
0.009 0.991 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.009 0.991 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.009 0.991 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.009 0.991 0.000
Y54.0 Mineralocorticoids
0.009 0.991 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.008 0.991 0.000
Y45.4 Antirheumatics
0.008 0.991 0.000
Y45.1 Salicylates
0.008 0.991 0.000
Y57.7 Vitamins, not elsewhere classified
0.008 0.992 0.000
Y57.6 Other diagnostic agents
0.008 0.992 0.000
Y57.4 Pharmaceutical excipients
0.008 0.992 0.000
Y57.3 Alcohol deterrents
0.008 0.992 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.008 0.992 0.000
Y57.1 Lipotropic drugs
0.008 0.992 0.000
Y57.0 Appetite depressants [anorectics]
0.008 0.992 0.000
E14 Unspecified diabetes mellitus
0.000 0.992 0.008
Y53.1 Other antacids and anti-gastric-secretion drugs
0.008 0.992 0.000
E10.1 With ketoacidosis
0.000 0.992 0.008
Y43.4 Immunosuppressive agents
0.008 0.992 0.000
Y45.8 Other analgesics and antipyretics
0.008 0.992 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.008 0.992 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.008 0.992 0.000
Y53.7 Emetics
0.008 0.992 0.000
Y53.6 Antidiarrhoeal drugs
0.008 0.992 0.000
Y53.5 Digestants
0.008 0.992 0.000
Y53.3 Saline and osmotic laxatives
0.008 0.992 0.000
Y53.2 Stimulant laxatives
0.008 0.992 0.000
Y53.0 Histamine H2-receptor antagonists
0.008 0.992 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.008 0.992 0.000
E10.5 With peripheral circulatory complications
0.000 0.992 0.008
Y53.4 Other laxatives
0.008 0.992 0.000
E14.9 Without complications
0.000 0.992 0.008
Y48.5 Therapeutic gases
0.008 0.992 0.000
Y48.4 Anaesthetic, unspecified
0.008 0.992 0.000
Y48.3 Local anaesthetics
0.008 0.992 0.000
Y48.2 Other and unspecified general anaesthetics
0.008 0.992 0.000
Y48.1 Parenteral anaesthetics
0.008 0.992 0.000
Y48.0 Inhaled anaesthetics
0.008 0.992 0.000
Y50.9 Central nervous system stimulant, unspecified
0.008 0.992 0.000
Y50.8 Other central nervous system stimulants
0.008 0.992 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.008 0.992 0.000
Y50.1 Opioid receptor antagonists
0.008 0.992 0.000
Y50.0 Analeptics
0.008 0.992 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.008 0.992 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.008 0.992 0.000
Y55.5 Anticommon cold drugs
0.008 0.992 0.000
Y55.4 Expectorants
0.008 0.992 0.000
Y55.3 Antitussives
0.008 0.992 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.008 0.992 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.008 0.992 0.000
Y55.0 Oxytocic drugs
0.008 0.992 0.000
Y58.9 Other and unspecified bacterial vaccines
0.008 0.992 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.008 0.992 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.008 0.992 0.000
Y58.5 Diphtheria vaccine
0.008 0.992 0.000
Y58.4 Tetanus vaccine
0.008 0.992 0.000
Y58.3 Plague vaccine
0.008 0.992 0.000
Y58.2 Cholera vaccine
0.008 0.992 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.008 0.992 0.000
Y58.0 BCG vaccine
0.008 0.992 0.000
Y59.9 Vaccine or biological substance, unspecified
0.008 0.992 0.000
Y59.8 Other specified vaccines and biological substances
0.008 0.992 0.000
Y59.3 Immunoglobulin
0.008 0.992 0.000
Y59.2 Protozoal vaccines
0.008 0.992 0.000
Y59.1 Rickettsial vaccines
0.008 0.992 0.000
Y59.0 Viral vaccines
0.008 0.992 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.008 0.992 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.008 0.992 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.008 0.992 0.000
Y47.4 Bromine compounds
0.008 0.992 0.000
Y47.3 Paraldehyde
0.008 0.992 0.000
Y47.2 Chloral derivatives
0.008 0.992 0.000
Y47.0 Barbiturates, not elsewhere classified
0.008 0.992 0.000
Y47.1 Benzodiazepines
0.008 0.992 0.000
Y54.3 Benzothiadiazine derivatives
0.008 0.992 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.008 0.992 0.000
Y44.7 Plasma substitutes
0.008 0.992 0.000
Y44.6 Natural blood and blood products
0.008 0.992 0.000
Y44.5 Thrombolytic drugs
0.008 0.992 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.008 0.992 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.008 0.992 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.008 0.992 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.008 0.992 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.008 0.992 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.008 0.992 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.008 0.992 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.008 0.992 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.008 0.992 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.008 0.992 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.008 0.992 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.008 0.992 0.000
Y51.0 Anticholinesterase agents
0.008 0.992 0.000
I47.2 Ventricular tachycardia
0.000 0.992 0.008
Y45.5 4-Aminophenol derivatives
0.008 0.992 0.000
Y44.2 Anticoagulants
0.008 0.992 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.008 0.992 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.008 0.992 0.000
Y56.9 Topical agent, unspecified
0.007 0.992 0.000
Y56.8 Other topical agents
0.007 0.992 0.000
Y56.7 Dental drugs, topically applied
0.007 0.992 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.007 0.992 0.000
Y56.5 Ophthalmological drugs and preparations
0.007 0.992 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.007 0.992 0.000
Y56.3 Emollients, demulcents and protectants
0.007 0.992 0.000
Y56.2 Local astringents and local detergents
0.007 0.992 0.000
Y56.1 Antipruritics
0.007 0.992 0.000
K76.6 Portal hypertension
0.000 0.992 0.008
K73 Chronic hepatitis, not elsewhere classified
0.000 0.993 0.007
K77 Liver disorders in diseases classified elsewhere
0.000 0.993 0.007
K71 Toxic liver disease
0.000 0.993 0.007
E10.2 With renal complications
0.000 0.993 0.007
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.007 0.993 0.000
E12 Malnutrition-related diabetes mellitus
0.000 0.993 0.007
E14.3 With ophthalmic complications
0.000 0.993 0.007
E10.8 With unspecified complications
0.000 0.993 0.007
E10.7 With multiple complications
0.000 0.993 0.007
E10.0 With coma
0.000 0.993 0.007
E10.4 With neurological complications
0.000 0.994 0.006
E14.7 With multiple complications
0.000 0.994 0.006
E14.6 With other specified complications
0.000 0.994 0.006
E14.4 With neurological complications
0.000 0.994 0.006
E14.2 Withrenal complications
0.000 0.994 0.006
E14.1 With ketoacidosis
0.000 0.994 0.006
E14.0 With coma
0.000 0.994 0.006
E10.6 With other specified complications
0.000 0.994 0.006
E10.9 Without complications
0.000 0.994 0.006
Y52 Agents primarily affecting the cardiovascular system
0.006 0.994 0.000
L57 Skin changes due to chronic exposure to nonionising radiation
0.000 0.994 0.006
E10.3 With ophthalmic complications
0.000 0.994 0.006
Y40 Systemic antibiotics
0.006 0.994 0.000
K72 Hepatic failure, not elsewhere classified
0.000 0.994 0.006
E11.9 Without complications
0.000 0.994 0.006
Y57.5 X-ray contrast media
0.005 0.994 0.000
K73.2 Chronic active hepatitis, not elsewhere classified
0.000 0.994 0.006
E14.5 With peripheral circulatory complications
0.000 0.994 0.005
K74 Fibrosis and cirrhosis of liver
0.000 0.994 0.005
E13 Other specified diabetes mellitus
0.000 0.994 0.005
K73.8 Other chronic hepatitis, not elsewhere classified
0.000 0.995 0.005
K73.1 Chronic lobular hepatitis, not elsewhere classified
0.000 0.995 0.005
K73.0 Chronic persistent hepatitis, not elsewhere classified
0.000 0.995 0.005
K71.9 Toxic liver disease, unspecified
0.000 0.995 0.005
K71.8 Toxic liver disease with other disorders of liver
0.000 0.995 0.005
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver
0.000 0.995 0.005
K71.6 Toxic liver disease with hepatitis, not elsewhere classified
0.000 0.995 0.005
K71.5 Toxic liver disease with chronic active hepatitis
0.000 0.995 0.005
K71.4 Toxic liver disease with chronic lobular hepatitis
0.000 0.995 0.005
K71.3 Toxic liver disease with chronic persistent hepatitis
0.000 0.995 0.005
K71.2 Toxic liver disease with acute hepatitis
0.000 0.995 0.005
K71.1 Toxic liver disease with hepatic necrosis
0.000 0.995 0.005
K71.0 Toxic liver disease with cholestasis
0.000 0.995 0.005
K77.8 Liver disorders in other diseases classified elsewhere
0.000 0.995 0.005
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere
0.000 0.995 0.005
E14.8 With unspecified complications
0.000 0.995 0.005
E12.9 Without complications
0.000 0.995 0.005
E12.8 With unspecified complications
0.000 0.995 0.005
E12.7 With multiple complications
0.000 0.995 0.005
E12.6 With other specified complications
0.000 0.995 0.005
E12.5 With peripheral circulatory complications
0.000 0.995 0.005
E12.4 With neurological complications
0.000 0.995 0.005
E12.3 With ophthalmic complications
0.000 0.995 0.005
E12.2 With renal complications
0.000 0.995 0.005
E12.1 With ketoacidosis
0.000 0.995 0.005
E12.0 With coma
0.000 0.995 0.005
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.005 0.995 0.000
K73.9 Chronic hepatitis, unspecified
0.000 0.995 0.005
I65.2 Occlusion and stenosis of carotid artery
0.000 0.995 0.005
I47.1 Supraventricular tachycardia
0.000 0.995 0.005
K74.0 Hepatic fibrosis
0.000 0.995 0.005
E83.5 Disorders of calcium metabolism
0.000 0.995 0.005
Y40.1 Cefalosporins and other -lactam antibiotics
0.004 0.995 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.004 0.995 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.004 0.995 0.000
Y52.7 Peripheral vasodilators
0.004 0.995 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.004 0.995 0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified
0.000 0.995 0.004
L57.5 Actinic granuloma
0.000 0.995 0.004
L57.3 Poikiloderma of Civatte
0.000 0.995 0.004
L57.2 Cutis rhomboidalis nuchae
0.000 0.995 0.004
L57.1 Actinic reticuloid
0.000 0.995 0.004
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.004 0.995 0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms
0.005 0.995 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.